ENO1 and breast cancer: Interestingly, analysis of the metastatic BC cohorts (Figure 5B) showed 7% genomic alterations (gene amplifications, deletions missense, and truncating mutations) potentially highlighting that alterations in the ENO1 gene are acquired during treatment and could be related to disease progression and metastasis.